These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21487894)

  • 1. CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis.
    Álvarez-Quiroga C; Abud-Mendoza C; Doníz-Padilla L; Juárez-Reyes A; Monsiváis-Urenda A; Baranda L; González-Amaro R
    J Clin Immunol; 2011 Aug; 31(4):588-95. PubMed ID: 21487894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
    Picchianti Diamanti A; Rosado MM; Scarsella M; Germano V; Giorda E; Cascioli S; Laganà B; D'Amelio R; Carsetti R
    Clin Exp Immunol; 2014 Sep; 177(3):630-40. PubMed ID: 24773026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.
    Bonelli M; Göschl L; Blüml S; Karonitsch T; Hirahara K; Ferner E; Steiner CW; Steiner G; Smolen JS; Scheinecker C
    Rheumatology (Oxford); 2016 Apr; 55(4):710-20. PubMed ID: 26672908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helios Enhances Treg Cell Function in Cooperation With FoxP3.
    Takatori H; Kawashima H; Matsuki A; Meguro K; Tanaka S; Iwamoto T; Sanayama Y; Nishikawa N; Tamachi T; Ikeda K; Suto A; Suzuki K; Kagami S; Hirose K; Kubo M; Hori S; Nakajima H
    Arthritis Rheumatol; 2015 Jun; 67(6):1491-502. PubMed ID: 25733061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subpopulations of Regulatory T-lymphocytes in the Peripheral Blood of Patients with Rheumatoid Arthritis].
    Kravchenko PN; Zhulai GA; Churov AV; Oleinik EK; Oleinik VM; Barysheva OY; Vezikova NN; Marusenko IM
    Vestn Ross Akad Med Nauk; 2016; (2):148-53. PubMed ID: 27522716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
    Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
    Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression.
    Ren CF; Zhao YX; Hou CF; Luan L; Duan GQ; Li SJ; Zhao JH
    Mol Med Rep; 2017 Jan; 15(1):460-466. PubMed ID: 27909722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
    Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10-producing LAG3
    Nakachi S; Sumitomo S; Tsuchida Y; Tsuchiya H; Kono M; Kato R; Sakurai K; Hanata N; Nagafuchi Y; Tateishi S; Kanda H; Okamura T; Yamamoto K; Fujio K
    Arthritis Res Ther; 2017 May; 19(1):97. PubMed ID: 28511719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis.
    Han GM; O'Neil-Andersen NJ; Zurier RB; Lawrence DA
    Cell Immunol; 2008; 253(1-2):92-101. PubMed ID: 18649874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
    Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
    J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.
    Pieper J; Herrath J; Raghavan S; Muhammad K; Vollenhoven Rv; Malmström V
    BMC Immunol; 2013 Aug; 14():34. PubMed ID: 23915385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (99) Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral γδ T cells and CD4(+) CD25(+) Foxp3(+) Tregs.
    Su D; Shen M; Gu B; Wang X; Wang D; Li X; Sun L
    Int J Rheum Dis; 2016 Jun; 19(6):586-93. PubMed ID: 24467668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Kumon Y; Hirata S; Takaoka H
    Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tim3
    Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
    Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
    Benito-Miguel M; García-Carmona Y; Balsa A; Pérez de Ayala C; Cobo-Ibáñez T; Martín-Mola E; Miranda-Carús ME
    J Immunol; 2009 Dec; 183(12):8268-79. PubMed ID: 20007590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.
    Moret FM; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheumatol; 2015 Mar; 67(3):637-44. PubMed ID: 25469671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.